INTERNATIONAL PATENT: HANMI PHARM. CO., LTD., 한미약품 주식회사 FILES APPLICATION FOR "TRIPLE ACTIVATOR HAVING ACTIVITY IN ALL OF GLP-1, GIP AND GLUCAGON RECEPTOR AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CARDIOVASCULAR DISEASES COMPRISING SAME"

GENEVA, Dec. 23 -- HANMI PHARM. CO., LTD. (214, Muha-ro, Paltan-myeon,Hwaseong-si,Gyeonggi-do 18536), 한미약품 주식회사 (경기도화성시팔탄면 무하로 214) filed a patent application (PCT/KR2025/008184) for "TRIPLE ACTIVATOR HAVING ACTIVITY IN ALL OF GLP-1, GIP, AND GLUCAGON RECEPTOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CARDIOVASCULAR DISEASES COMPRISING SAME" on Jun 13, 2025. With publication no. WO/2025/259064, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is ma...